Aiosyn: Funding, Investors & Team (Sep 2026)
Aiosyn uses artificial intelligence to develop algorithms to augment pathologist with clinical decision-making. The company develops a clinical diagnostics platform with multiple AI algorithms and connect with standard pathology workflows. Aiosyn's platform will also accelerate biopharma and diagnostics companies with developing AI-based biomarker development.
Aiosyn has raised $2.2M across 2 funding rounds on record, the most recent a Seed of $2.1M announced in Dec 2022.
That round is below the $5.5M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Aiosyn Company Profile and Key Stats
Latest funding round on record: Dec 2022.
Aiosyn Funding Rounds
Aiosyn raised $100k in a Pre-Seed announced in Feb 2022.
10 months later, a Seed of $2.1M was announced in Dec 2022.
Aiosyn Founders and Leadership Team
Contact details for the Aiosyn team: 1 of 2 have an email address on file.
Start 14-day free trial →Aiosyn Funding Compared to Other Artificial Intelligence Startups
Aiosyn's latest round of $2.1M is below the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Aiosyn in Artificial Intelligence and Nijmegen
Companies Similar to Aiosyn
Billy Grace provides marketing solutions which include analytics, automation, creativity, artificial…
ScreenPoint develops Deep Learning and image analysis technology for automated reading of mammograms and…
Axelera AI is developing a game-changing hardware and software platform for AI. Incubated in 2019 by the…
Helin offers a software-as-a-service solution that integrates edge control, cloud data processing, and remote…
Orq.ai offers businesses the ability to utilize Large Language Models effectively through a unified platform,…
Heathplus.ai re-uses electronic health record data to predict complications after surgery. This enables…
Overstory applies artificial intelligence to high-resolution satellite imagery to provide real-time analytics…
The goal of Clearbio is to provide billions of people with a healthier lifestyle through smart food choices,…
Whisper, a cybersecurity startup located in Amsterdam, has recently come out of stealth mode to tackle the…
Perry utilizes AI technology to produce and distribute easy-to-follow work and safety guidelines. Their…
Dexter offers forecasting and dispatching solutions based on AI and cloud-based technology, increasing…
ScoutinScience utilizes the SiS-AI platform technology to search through scientific journals and publications…
Aiosyn Funding FAQs
What does Aiosyn do?
Aiosyn uses artificial intelligence to develop algorithms to augment pathologist with clinical decision-making. The company develops a clinical diagnostics platform with multiple AI algorithms and connect with standard pathology workflows. Aiosyn's platform will also accelerate biopharma and diagnostics companies with developing AI-based biomarker development.
How much funding has Aiosyn raised?
Aiosyn has raised $2.2M across 2 rounds on record. The most recent is a Seed of $2.1M announced in Dec 2022.
When did Aiosyn last raise funding?
Aiosyn's most recent funding round on record is a Seed of $2.1M, announced in Dec 2022.
Who founded Aiosyn?
FundedIQ lists Wouter Bulten (Founder) at Aiosyn.
Who is the CEO of Aiosyn?
Patrick de Boer is listed as CEO at Aiosyn.
Where is Aiosyn headquartered?
Aiosyn is based in Nijmegen, Gelderland, Netherlands.
How many employees does Aiosyn have?
Aiosyn is in the 1-10 employee band.
How does Aiosyn's funding compare to other Artificial Intelligence startups?
Aiosyn's latest round of $2.1M is below the $5.5M median round size for Artificial Intelligence companies on FundedIQ across 7,233 tracked companies over the last two years.
About FundedIQ's Aiosyn Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Aiosyn is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.